Neurol India Home 
 

NI FEATURE: THE EDITORIAL DEBATE I-- PROS AND CONS
Year : 2018  |  Volume : 66  |  Issue : 1  |  Page : 38--39

Botulinum toxin in patients with Meige's syndrome

Nirosen Vijiaratnam, Tissa Wijeratne 
 Department of Medicine and Neurology, Melbourne Medical School, The University of Melbourne and Western Health, Sunshine Hospital, St Albans, Victoria, Australia

Correspondence Address:
Dr. Tissa Wijeratne
Department of Medicine and Neurology, Melbourne Medical School, The University of Melbourne and Western Health, Sunshine Hospital, 176 Furlong Rd, St Albans VIC 3021
Australia




How to cite this article:
Vijiaratnam N, Wijeratne T. Botulinum toxin in patients with Meige's syndrome.Neurol India 2018;66:38-39


How to cite this URL:
Vijiaratnam N, Wijeratne T. Botulinum toxin in patients with Meige's syndrome. Neurol India [serial online] 2018 [cited 2019 May 19 ];66:38-39
Available from: http://www.neurologyindia.com/article.asp?issn=0028-3886;year=2018;volume=66;issue=1;spage=38;epage=39;aulast=Vijiaratnam;type=0